These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1581114)

  • 1. Clinical use of biochemical markers of bone remodeling in osteoporosis.
    Delmas PD
    Bone; 1992; 13 Suppl 1():S17-21. PubMed ID: 1581114
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between bone formation rate and osteoblast surface on different subdivisions of the endosteal envelope in aging & osteoporosis.
    Shih MS; Cook MA; Spence CA; Palnitkar S; McElroy H; Parfitt AM
    Bone; 1993; 14(3):519-21. PubMed ID: 8363902
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels.
    Eriksen EF; Hodgson SF; Eastell R; Cedel SL; O'Fallon WM; Riggs BL
    J Bone Miner Res; 1990 Apr; 5(4):311-9. PubMed ID: 2343771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sympathetic nervous system and bone remodeling.
    Chenu C; Marenzana M
    Joint Bone Spine; 2005 Dec; 72(6):481-3. PubMed ID: 16325450
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased bone resorption precedes increased bone formation in the ovariectomized rat.
    Sims NA; Morris HA; Moore RJ; Durbridge TC
    Calcif Tissue Int; 1996 Aug; 59(2):121-7. PubMed ID: 8687981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone turnover markers: a key tool for understanding osteoporosis.
    Eastell R; Ebeling PR
    Osteoporos Int; 2009 May; 20 Suppl 3():S237-8. PubMed ID: 19430871
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical markers of bone remodeling.
    Kleerekoper M
    Am J Med Sci; 1996 Dec; 312(6):270-7. PubMed ID: 8969616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bone following the menopause].
    Peretz A
    Rev Med Brux; 1995; 16(4):280-4. PubMed ID: 7481243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the clinical significance of biochemical markers of growth and bone metabolism?
    Argente J; HeinegÄrd D
    Acta Paediatr Suppl; 1994 Dec; 406():99-102. PubMed ID: 7734821
    [No Abstract]   [Full Text] [Related]  

  • 10. Bone turnover markers in the management of postmenopausal osteoporosis.
    Brown JP; Albert C; Nassar BA; Adachi JD; Cole D; Davison KS; Dooley KC; Don-Wauchope A; Douville P; Hanley DA; Jamal SA; Josse R; Kaiser S; Krahn J; Krause R; Kremer R; Lepage R; Letendre E; Morin S; Ooi DS; Papaioaonnou A; Ste-Marie LG
    Clin Biochem; 2009 Jul; 42(10-11):929-42. PubMed ID: 19362543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markers of bone remodelling in metabolic bone disease.
    de Vernejoul MC
    Drugs Aging; 1998; 12 Suppl 1():9-14. PubMed ID: 9673861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone quality--the material and structural basis of bone strength and fragility.
    Seeman E; Delmas PD
    N Engl J Med; 2006 May; 354(21):2250-61. PubMed ID: 16723616
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis.
    Seeman E
    Osteoporos Int; 2003; 14 Suppl 3():S2-8. PubMed ID: 12730770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical markers of bone metabolism in the assessment of osteoporosis: useful or not?
    Seibel MJ
    J Endocrinol Invest; 2003 May; 26(5):464-71. PubMed ID: 12906376
    [No Abstract]   [Full Text] [Related]  

  • 15. The performance and utility of biochemical markers of bone turnover: do we know enough to use them in clinical practice?
    Blumsohn A; Eastell R
    Ann Clin Biochem; 1997 Sep; 34 ( Pt 5)():449-59. PubMed ID: 9293302
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biochemical markers of bone remodeling in the prevention of postmenopausal osteoporosis].
    Calleri L; Porcelli A; Surico N
    Minerva Ginecol; 1998 Oct; 50(10):423-8. PubMed ID: 9866953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of bone turnover in postmenopause, vertebral fracture, and hip fracture using biochemical markers for bone formation and resorption.
    Takahashi M; Kushida K; Hoshino H; Ohishi T; Inoue T
    J Endocrinol Invest; 1997 Mar; 20(3):112-7. PubMed ID: 9186815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls.
    Cremers S; Garnero P
    Drugs; 2006; 66(16):2031-58. PubMed ID: 17112299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markers of bone turnover: consideration on their clinical application in osteoporosis.
    Cantatore FP; Pipitone V
    Panminerva Med; 1999 Sep; 41(3):247-51. PubMed ID: 10568124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of biochemical markers of bone turnover by kinetic measures of bone formation and resorption in young healthy females.
    Weaver CM; Peacock M; Martin BR; McCabe GP; Zhao J; Smith DL; Wastney ME
    J Bone Miner Res; 1997 Oct; 12(10):1714-20. PubMed ID: 9333133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.